Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Dianthus Therapeutics, Inc. /DE/ (DNTH), most recent 12 months reported: revenue $2.04M, net loss $192.25M, free cash flow -$155.71M. Latest balance sheet on file: liquid cash $886.81M. From SEC filings. More on Dianthus Therapeutics, Inc. /DE/: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: VISTAGEN THERAPEUTICS, INC. · Korro Bio, Inc. · NORTHWEST BIOTHERAPEUTICS INC · CYCLERION THERAPEUTICS, INC. · ORAMED PHARMACEUTICALS INC. · Seres Therapeutics, Inc. · CANNAPHARMARX, INC. · Ovid Therapeutics Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.